Park Square has placed Michael Aldridge as Chief Executive Officer at Focal Medical.
Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform, today announced the appointment of Michael Aldridge as the Company’s new Chief Executive Officer.
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
